This is a story about an effective anticancer agent that receives no recognition, since it cannot be patented for profit. The graphics of the film may be dated, but the story has saved many lives and inspired new research.
In July 2, 1974, records on cancer research were obtained from the Sloan-Kettering Institute under the Freedom-of-Information Act. The records revealed that The Sloan-Kettering Institute for Cancer Research had meticulously tested an anticancer agent known as Laetrile. They had concluded that it could stop metastasis in mice, inhibit growth of smaller tumors, give relief from pain, prevent cancer and improve health in general.
But the Sloan Kettering Board was not pleased, as they were only interested in finding high-priced drug cures which could be patented. For them, there was no money to be made from food enzymes with vitamin B17.
19/5/07
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment